Intra-aortic balloon pump: indications, efficacy, guidelines and future directions

Area of Science:

• Cardiology
• Cardiovascular Interventions
• Medical Device Efficacy

Background:

• The intra-aortic balloon pump (IABP) has been a cardiac assist device since 1968, primarily based on physiological principles and observational data.
• Limited randomized controlled trials (RCTs) have historically constrained understanding of IABP's clinical effectiveness.

Purpose of the Study:

• To review recent randomized data on the efficacy and safety of the intra-aortic balloon pump (IABP).
• To evaluate IABP's role in acute myocardial infarction (MI), high-risk percutaneous coronary intervention (PCI), and coronary artery bypass graft (CABG) surgery.

Main Methods:

• Analysis of recently published randomized controlled trials (RCTs) and meta-analyses.
• Review of observational data for specific indications where RCTs are lacking.

Main Results:

• Recent RCTs and meta-analyses confirm the safety of IABP but question its efficacy in acute MI, with or without cardiogenic shock.
• Limited support exists for IABP's efficacy in high-risk PCI and CABG, with only observational data for niche indications like mechanical MI complications and refractory ventricular arrhythmia.

Conclusions:

• Current evidence supports IABP safety but provides limited or no support for its efficacy in high-risk MI, cardiogenic shock, or prophylactic use in high-risk PCI/CABG.
• Further studies are essential to optimize patient selection, timing, and adjunctive therapies to define IABP's role in contemporary cardiovascular practice.